QuantLogix

MRNA vs PFE — live signal comparison

Head-to-head on QuantLogix's 5-factor quant engine, recomputed throughout the trading day. An engine-read comparison — not a recommendation.

MRNA
Moderna, Inc. Common Stock
79/100
STRONG BUY
$193.66 · -3.19% · $61.5B
Full scorecard →
VS
engine lead
PFE
Pfizer Inc.
91/100
STRONG BUY
$29.84 · +0.15% · $157.7B
40% of similar setups up in 5d
Full scorecard →
Factor by factor — MRNA (left) vs PFE (right)
62
Technical
78
65
Momentum
60
40
Fundamental
48
45
Options
54
89
Microstructure
95

QuantLogix's 5-factor engine currently reads Moderna, Inc. Common Stock (MRNA) at 79/100 (strong buy) and Pfizer Inc. (PFE) at 91/100 (strong buy). PFE carries the stronger composite read by 12 points, led by microstructure at 95/100. MRNA's strongest leg is microstructure at 89/100. Signals recompute throughout the trading day — the balance can shift with the tape.

Track PFE with free signal alerts Browse all scorecards
🤖 Want the deeper take? Pro runs a 10-agent AI debate on either name — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. MRNA scorecard · PFE scorecard · MRNA earnings · PFE earnings · Today's movers · Verified track record